Bio-Rad Laboratories, Inc. (BIO)
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company operates through followings segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. Bio-Rad Laboratories was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
|Market Price at 17-11-2017||$255.49|
|Price to Earnings Ratio||191.86|
|Market Capitalisation||$7,677.47 (million)|
|Return on Equity (ROE)||1.09%|